707 related articles for article (PubMed ID: 3944211)
1. Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia.
Kimura H; Finch CA; Adamson JW
J Cell Physiol; 1986 Feb; 126(2):298-306. PubMed ID: 3944211
[TBL] [Abstract][Full Text] [Related]
2. Megakaryocytopoiesis in the rat: response to thrombocytopenia induced by exchange transfusion.
Kimura H; Segal GM; Lee MY; Adamson JW
Exp Hematol; 1985 Nov; 13(10):1048-54. PubMed ID: 4054245
[TBL] [Abstract][Full Text] [Related]
3. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
4. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
5. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
6. Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice.
Goris H; Bungart B; Loeffler M; Schmitz S; Nijhof W
Exp Hematol; 1990 Jun; 18(5):400-7. PubMed ID: 2338129
[TBL] [Abstract][Full Text] [Related]
7. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
8. Effects of cadmium on in vitro and in vivo erythropoiesis: erythroid progenitor cells (CFU-E), iron, and erythropoietin in cadmium-induced iron deficiency anemia.
Sakata S; Iwami K; Enoki Y; Kohzuki H; Shimizu S; Matsuda M; Moriyama T
Exp Hematol; 1988 Aug; 16(7):581-7. PubMed ID: 3391251
[TBL] [Abstract][Full Text] [Related]
9. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
10. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
Broxmeyer HE; Williams DE; Hangoc G; Cooper S; Gentile P; Shen RN; Ralph P; Gillis S; Bicknell DC
Blood Cells; 1987; 13(1-2):31-48. PubMed ID: 3499193
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cells in the hereditarily anemic Belgrade laboratory (b/b) rat.
Ivanović Z; Milenković P; Vasiljevska M; Dekić M
Exp Hematol; 1995 Oct; 23(11):1218-23. PubMed ID: 7556533
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic growth factors in anemia of Belgrade laboratory (b/b) rats.
Biljanović-Paunović L; Stojanović N; Mostarica-Stojković M; Ramić Z; Ivanović Z; Basara N; Clemons GK; Pavlović-Kentera V
Exp Hematol; 1992 Dec; 20(11):1257-62. PubMed ID: 1493855
[TBL] [Abstract][Full Text] [Related]
14. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
15. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
Soderberg LS; Flick JT; Barnett JB
Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow failure following severe injury in humans.
Livingston DH; Anjaria D; Wu J; Hauser CJ; Chang V; Deitch EA; Rameshwar P
Ann Surg; 2003 Nov; 238(5):748-53. PubMed ID: 14578739
[TBL] [Abstract][Full Text] [Related]
17. Retrovirus-induced feline pure red cell aplasia: the kinetics of erythroid marrow failure.
Abkowitz JL; Holly RD; Adamson JW
J Cell Physiol; 1987 Sep; 132(3):571-7. PubMed ID: 2821017
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
19. Method for growing primitive erythroid progenitors (BFU-E) from rat bone marrow.
Basara N; Biljanović-Paunović L; Pavlović-Kentera V
Exp Hematol; 1988 Oct; 16(9):790-3. PubMed ID: 3169160
[TBL] [Abstract][Full Text] [Related]
20. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev).
Van Zant G; Shultz L
Exp Hematol; 1989 Feb; 17(2):81-7. PubMed ID: 2783574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
